CLCF1-CNTFR signaling is emerging as a target for specific therapy for non-small-cell lung cancer (NSCLC) [53,54,55], while nothing has previously been evaluated for SCLC. This evidence concerns the gene CLCF1 and non-small cell lung carcinoma.